Andrew D Sklawer - Net Worth and Insider Trading

Andrew D Sklawer Net Worth

The estimated net worth of Andrew D Sklawer is at least $2,547 dollars as of 2024-06-10. Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc and owns about 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $2,547. Details can be seen in Andrew D Sklawer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew D Sklawer has not made any transactions after 2021-05-17 and currently still holds the listed stock(s).

Transaction Summary of Andrew D Sklawer

To

Andrew D Sklawer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew D Sklawer owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .

Click here to see the complete history of Andrew D Sklawer’s form 4 insider trades.

Insider Ownership Summary of Andrew D Sklawer

Ticker Comapny Transaction Date Type of Owner
FRTX Fresh Tracks Therapeutics Inc 2021-06-14 COO and Secretary

Andrew D Sklawer Latest Holdings Summary

Andrew D Sklawer currently owns a total of 1 stock. Andrew D Sklawer owns 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) as of May 17, 2021, with a value of $2,547.

Latest Holdings of Andrew D Sklawer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FRTX Fresh Tracks Therapeutics Inc 2021-05-17 2,769 0.92 2,547

Holding Weightings of Andrew D Sklawer


Andrew D Sklawer Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew D Sklawer has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 342 shares on May 17, 2021, which cost Andrew D Sklawer around $12,300.

Insider Trading History of Andrew D Sklawer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew D Sklawer Trading Performance

GuruFocus tracks the stock performance after each of Andrew D Sklawer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D Sklawer is -22.96%. GuruFocus also compares Andrew D Sklawer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D Sklawer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew D Sklawer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew D Sklawer

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.37 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.96 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew D Sklawer Ownership Network

Ownership Network List of Andrew D Sklawer

No Data

Ownership Network Relation of Andrew D Sklawer

Insider Network Chart

Andrew D Sklawer Owned Company Details

What does Fresh Tracks Therapeutics Inc do?

Who are the key executives at Fresh Tracks Therapeutics Inc?

Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .

Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary

Over the past 18 months, Andrew D Sklawer made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 386,399 shares, with a net purchase of 386,399 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 680,912 shares were bought by its insiders, resulting in a net purchase of 680,802 shares.

Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fresh Tracks Therapeutics Inc Insider Transactions

No Available Data

Andrew D Sklawer Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew D Sklawer. You might contact Andrew D Sklawer via mailing address: 5777 Central Avenue, Suite 102, Boulder Co 80301.

Discussions on Andrew D Sklawer

No discussions yet.